RN7SKP21

Across TCGA pan-cancer cohorts, RN7SKP21 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RN7SKP21 data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher RN7SKP21 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SKP21 expression acts as an unfavorable survival marker, although some lineages such as THCA and LGG show a favorable association.

PAAD, STAD, and ESCA are the cancer types where RN7SKP21 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	DFS	Tertile	All	0.142	0.486	.011	63	view →
STAD	OS	Tertile	II,III,IV	0.371	0.720	<.001	36	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
KIRP	OS	Tertile	All	0.101	0.688	.027	27	view →
BLCA	OS	Tertile	All	0.221	0.618	.041	18	view →
SKCM	DFS	Tertile	III,IV	0.058	0.648	.001	18	view →
SARC	OS	Tertile	All	0.511	0.860	.002	18	view →
UCEC	DFS	Tertile	All	0.775	0.899	.027	18	view →
THCA	OS	Median	All	1.000	0.908	.004	15	view →
LGG	OS	Quartile	All	0.854	0.687	.009	10	view →
LUSC	OS	Tertile	III,IV	0.284	0.674	.033	9	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RN7SKP21–PAAD (DFS)

Open the PAAD breakdown →